As regulatory deadlines loom, this bill is widely regarded as a pivotal turning point poised to reshape the developmental ...
Kratos Defense & Security Solutions, Inc. (NASDAQ: KTOS), a Technology Company in the Defense, National Security and Global Markets, announced today that it will publish financial results for the ...
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with ...
Investors and security holders will be able to obtain free copies of the registration statement, the joint proxy statement/prospectus and all other relevant documents filed or that will be filed with ...
Water Tower Place, the seminal shopping destination on Chicago’s Magnificent Mile, today shared redevelopment plans for the popular and historic shopping center. Announced as the center celebrates its ...
POET Technologies Inc. ("POET" or the "Company") (NASDAQ: POET), a leader in the design and implementation of highly-integrated optical engines and light sources for artificial intelligence networks, ...
All of the shares, pre-funded warrants and accompanying common stock warrants in the offering were sold by Altimmune. The gross proceeds from the offering before deducting underwriting discounts and ...
Suja Life, Inc. (“Suja Life”) today announced that it has commenced the roadshow for its proposed initial public offering. Suja Life has filed a registration statement on Form S-1 with the U.S.
The United States of America-Bond has a maturity date of 11/15/2032 and offers a coupon of 4.1250%. The payment of the coupon will take place 2,0 times per biannual on the 15.05.. At the current price ...
The government, which took a nearly 10% stake in Intel last August, has seen gains on paper of $27 billion following the big ...
The Senegal, Republik-Bond has a maturity date of 3/13/2028 and offers a coupon of 4.7500%. The payment of the coupon will ...
Acquisition Positions Amneal to Capitalize on $300B+ Global Biologics LOE Opportunity –– Transaction Accelerates Growth Profile and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results